| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.00052 | 1 |